ArticleMolecular therapy. Oncology2026

Reprogramming CXCL10-mediated NK cell trafficking to enhance immunotherapy in osteosarcoma.

William P Jayne et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.